With Fermion, start the journey of your innovative API.
01 1Fermion Oy
02 2Chunghwa Chemical Synthesis & Biotech Co., Ltd.
03 1Cambrex Charles City, Inc.
04 1G1 Therapeutics, Inc.
05 1HETERO LABS LIMITED
06 1Olon S.p.A.
01 1TRILACICLIB DIHYDROCHLORIDE
02 1TRILACICLIB DIHYDROCHLORIDE DIHYDRATE
03 1Trilaciclib Dihydrochloride
04 1Trilaciclib Dihydrochloride Dihydrate
05 1Trilaciclib dihydrochloride
06 2trilaciclib dihydrochloride dihydrate
01 1Finland
02 1India
03 1Italy
04 2Taiwan
05 2U.S.A
With Fermion, start the journey of your innovative API.
TRILACICLIB DIHYDROCHLORIDE DIHYDRATE
NDC Package Code : 12780-4780
Start Marketing Date : 2021-02-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6275
Start Marketing Date : 2022-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6280
Start Marketing Date : 2024-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TRILACICLIB DIHYDROCHLORIDE DIHYDRATE
NDC Package Code : 59116-6360
Start Marketing Date : 2021-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TRILACICLIB DIHYDROCHLORIDE DIHYDRATE
NDC Package Code : 73462-201
Start Marketing Date : 2021-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0166
Start Marketing Date : 2021-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0438
Start Marketing Date : 2024-05-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Trilaciclib Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trilaciclib Dihydrochloride, including repackagers and relabelers. The FDA regulates Trilaciclib Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trilaciclib Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trilaciclib Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trilaciclib Dihydrochloride supplier is an individual or a company that provides Trilaciclib Dihydrochloride active pharmaceutical ingredient (API) or Trilaciclib Dihydrochloride finished formulations upon request. The Trilaciclib Dihydrochloride suppliers may include Trilaciclib Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Trilaciclib Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trilaciclib Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trilaciclib Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trilaciclib Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trilaciclib Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trilaciclib Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trilaciclib Dihydrochloride suppliers with NDC on PharmaCompass.
We have 6 companies offering Trilaciclib Dihydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
